High-Throughput Screening and Automation

  • Home
  • High-Throughput Screening and Automation

High-Throughput & High-Content Screening and Automation

At Axela Biosciences, we combine cutting-edge automation, precision assays, and deep scientific expertise to drive high-throughput and high-content screening (HTS/HCS) solutions for drug discovery. Whether you’re screening thousands of compounds or conducting detailed phenotypic profiling, our platforms are built to accelerate your path to the clinic—with speed, scale, and scientific rigor.

What We Offer:
High-Throughput Screening (HTS)
  • Accelerate early-stage discovery with scalable screening capabilities across diverse therapeutic areas:
  • Small molecule, peptide, and biologics libraries
  • Enzyme and cell-based functional assays
  • Target binding and engagement studies
  • Cytotoxicity and viability screens
  • Biomarker and reporter-based readouts
  • Dose-response profiling and hit validation
Automation & Assay Miniaturization

We utilize advanced instruments and miniaturized assay formats to increase throughput, reduce sample use, and enhance reproducibility:

  • Automated plate setup (96-, 384-, and 1536-well formats)
  • Precision reagent dispensing and compound handling
  • Integrated data acquisition and real-time analysis
  • Miniaturized assays for cost-effective screening
  • Custom protocol design and flexible platform integration
High-Content Screening (HCS)
  • Unlock rich, multi-parametric data using advanced imaging and multiplexed detection:
  • Automated imaging-based phenotypic analysis
  • Subcellular localization and trafficking studies
  • Cell morphology and marker colocalization
  • Spatial multi-omics (gene and protein expression)
  • Immune profiling and mechanism-of-action (MoA) insights